RIZATRIPTAN BENZOATE
NDC 43817-133, rizatriptan benzoate, tablet, orally disintegrating, from Panacea Biotec Limited.
- Product NDC
- 43817-133
- Status
- Listed
- Labeler
- Panacea Biotec Limited
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204722
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43817-133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIZATRIPTAN BENZOATE5 mg/1
Pharmacologic classes
Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43817-133-04 | 43817013304 | 6 BLISTER PACK in 1 CARTON (43817-133-04) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (43817-133-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9c70370d-72ac-e062-e25c-97d57e6397ab
Use it
Look up 43817-133 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43817-133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43817-133. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.